On the other hand, Duan et al. showed that miR-26a-5p from ASC-exos also protects against diabetic nephropathy by targeting toll-like receptor 4 (TLR4), silencing the NF-κB pathway, and downregulating VEGF-A secretion [157]. This evidence concerns the gene TLR4 and diabetic kidney disease.